Skip to content

Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool

Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using Patient Health Questionnaire-9 as a Screening Tool

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04701632
Enrollment
150
Registered
2021-01-08
Start date
2019-10-28
Completion date
2021-05-11
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound

Brief summary

The objective of the study is to complete a retrospective chart review of subjects who were treated at the Wound Care Clinic at Methodist Dallas Medical Center, presented for treatment between June 2018 and February 2019, and were administered the Patient Health Questionnaire-9. The study aims to measure the prevalence of depression in this sample, feasibility of using Patient Health Questionnaire-9 in this patient population, and identifying variables and functional impairment associated with clinically significant depression.

Detailed description

The study will review medical records of new patients who presented to the Wound Care Center at Methodist Dallas Medical Center between June 2018 and February 2019. These patients were all administered Patient Health Questionnaire-9 as part of a quality improvement project. The medical records included for analysis will be from male and female patients aged 18 years or older. The medical records will be reviewed for the following information: general demographics, information including age, sex, ethnicity, race, Patient Health Questionnaire-9 score (total and individual items), medical conditions, wound history, past medical history, general symptoms, abuse and suicide risk, activities of daily living, motivation assessment, mental status, and pain ratings. This information will be used to measure the prevalence of clinically significant depression in the sample, which is the primary aim. We will also use the data to establish factors and variables correlated with the presence and severity of clinically significant depression.

Interventions

None listed

Sponsors

Methodist Health System
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 or older 2. Received care at the Wound Care Center at Methodist Dallas Medical Center between June 2018 and February 2019 3. Completed a PHQ-9 form at the time of initial evaluation/examination

Exclusion criteria

1\. Patients less than 18 years of age will be excluded from the study

Design outcomes

Primary

MeasureTime frameDescription
PHQ-9 scoreThrough study completion, an average of 1 yearto measure the prevalence of clinically significant depression defined as a PHQ-9 score of equal to or greater than 10.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAsma Khatoon, MD

The Methodist Hospital Research Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026